系统性红斑狼疮患者双酚A甲基化评分升高并与SLE风险基因及部分临床亚表型相关
研究纳入发现队列747例和复制队列388例瑞典SLE患者与健康对照,用Illumina HM450k芯片计算BPA敏感CpG位点评分。SLE患者BPASLE评分显著高于对照(发现队列OR 1.34,复制队列OR 1.28,Meta分析OR 1.32),两个评分均与泼尼松龙治疗相关,BPASLE评分与浆膜炎和自身抗体相关。
要点
- SLE患者BPASLE评分显著高于对照,Meta分析OR 1.32(p=3.3×10-17)。
- BPAAll评分仅在发现队列与SLE相关(OR 1.05),复制队列无显著关联(OR 1.04,p=0.12)。
- 两个评分均与泼尼松龙治疗相关(p<0.001),BPASLE评分与浆膜炎和自身抗体相关(p<0.05)。
核心结论
- 研究发现BPA暴露与SLE中DNA甲基化改变之间存在新关联,可能对免疫相关基因表达的调控具有潜在意义。
研究设计与样本
- 研究为发现队列(n=747)与复制队列(n=388)的病例对照研究,纳入瑞典SLE患者与健康对照,使用Illumina HM450k bead chip检测。
- BPA敏感CpG位点的筛选标准为在7项BPA暴露研究中至少2项显示差异甲基化并有细胞系数据支持。
- 计算了包含19个CpG的BPAAll评分和基于3个与SLE风险位点共定位CpG的BPASLE评分,并分析其与临床数据的关联。
- 将结果与BPA处理细胞的公开转录组数据进行比较。
主要发现
- SLE患者BPASLE评分显著高于对照:发现队列OR 1.34(p=4.6×10-13),复制队列OR 1.28(p=1.1×10-5),Meta分析OR 1.32(p=3.3×10-17)。
- BPAAll评分较高与SLE的关联仅在发现队列中显著(OR 1.05,p=2.3×10-3),复制队列中不显著(OR 1.04,p=0.12),Meta分析差异显著(OR 1.05,p=7.0×10-4)。
- 两个评分均与泼尼松龙治疗相关(p<0.001),BPASLE评分与浆膜炎和自身抗体相关(p<0.05)。
- BPA处理细胞的转录组分析显示干扰素和丝裂原活化蛋白激酶信号等通路富集。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Bisphenol A (BPA), a xenoestrogen that can alter DNA methylation status, has been implicated in the pathogenesis of systemic lupus erythematosus (SLE). This study aimed to investigate whether methylation changes at BPA-sensitive 5'-C-phosphate-G-3' (CpG) sites are associated with SLE and clinical subphenotypes. METHODS: A discovery cohort (n=747) and a replication cohort (n=388) including Swedish patients with SLE and healthy controls were investigated using the Illumina HM450k bead chip. BPA-sensitive CpG sites were selected if differentially methylated in ≥2 of 7 BPA exposure studies and supported by cell line data. A BPAAll score including 19 CpGs and a BPASLE score based on three CpG sites co-localised in the genome with SLE risk loci were calculated for each individual, analysed for associations with clinical data and then compared with publicly available transcriptomic data from BPA-treated cells. RESULTS: Patients with SLE had significantly higher BPASLE score than controls in the discovery (OR 1.34, p=4.6×10-13), replication (OR 1.28, p=1.1×10-5) and meta-analysis (OR 1.32, p=3.3×10-17). Higher BPAAll score was associated with SLE in the discovery cohort (OR 1.05, p=2.3×10-3) but not in the replication cohort (OR 1.04, p=0.12) with a significant difference in the meta-analysis (OR 1.05, p=7.0×10-4). Both scores were associated with prednisolone treatment (p<0.001), and the BPASLE score was associated with serositis and autoantibodies (p<0.05). Transcriptomic analysis of BPA-treated cells revealed enrichment in pathways such as interferon and mitogen-activated protein kinase signalling. CONCLUSIONS: Our findings reveal a novel association between BPA exposure and DNA methylation changes in SLE, with potential implications for the regulation of immune-related gene expression.
引用
- Vestin H, Oparina N, Eloranta ML, et al. Patients with systemic lupus erythematosus (SLE) have an increased bisphenol A methylation score linked to SLE risk genes and selected clinical subphenotypes. RMD Open. 2025. PMID: 40998523. doi:10.1136/rmdopen-2025-006021
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。